BROOKFIELD ORATION ($BN) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of $0.98 per share, beating estimates of $0.92 by $0.06. The company also reported revenue of $17,944,000,000, beating estimates of $1,451,270,000 by $16,492,730,000.
You can see Quiver Quantitative's $BN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BROOKFIELD ORATION Hedge Fund Activity
We have seen 321 institutional investors add shares of BROOKFIELD ORATION stock to their portfolio, and 346 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NATIONAL BANK OF CANADA /FI/ added 16,233,183 shares (+543.3%) to their portfolio in Q4 2024, for an estimated $932,596,363
- GOLDMAN SACHS GROUP INC removed 4,844,723 shares (-53.6%) from their portfolio in Q4 2024, for an estimated $278,329,336
- EDGEPOINT INVESTMENT GROUP INC. removed 3,348,364 shares (-29.1%) from their portfolio in Q4 2024, for an estimated $192,363,511
- BANK OF MONTREAL /CAN/ removed 2,795,836 shares (-5.3%) from their portfolio in Q4 2024, for an estimated $160,620,778
- LEGAL & GENERAL GROUP PLC removed 2,705,239 shares (-27.4%) from their portfolio in Q4 2024, for an estimated $155,415,980
- REGENTS OF THE UNIVERSITY OF CALIFORNIA added 2,683,035 shares (+inf%) to their portfolio in Q4 2024, for an estimated $154,140,360
- BANK OF NOVA SCOTIA removed 2,469,604 shares (-17.4%) from their portfolio in Q4 2024, for an estimated $141,878,749
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BROOKFIELD ORATION Analyst Ratings
Wall Street analysts have issued reports on $BN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 11/15/2024
To track analyst ratings and price targets for BROOKFIELD ORATION, check out Quiver Quantitative's $BN forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
